Skip to main content

Table 1 Clinical characteristics of the study groups

From: Maternal serum glycosylated fibronectin as a short-term predictor of preeclampsia: a prospective cohort study

Ā 

At-risk women without PE

At-risk women with PE

p-value

n

119

32

Ā 

Maternal Characteristics

ā€ƒGestational age at sample collection (wk)

29 (8.5)

30 (7.3)

0.14

ā€ƒMaternal age (yr)

33 (7.5)

33 (6.5)

0.74

ā€ƒMaternal weight pre-pregnancy (kg)

68 (23.8)

65.5 (16.5.)

0.7

ā€ƒMaternal weight at sample collection (kg)

78 (22.8)

80 (15.5)

0.71

ā€ƒMaternal BMI (kg/m2)

24.16 (7.8)

25.67 (5.5)

0.96

ā€ƒSystolic BP (mmHg)

124 (19)

160 (39)

<ā€‰0.001

ā€ƒDays before delivery

54 (72)

4 (10.8)

<ā€‰0.001

ā€ƒEthnicity: Caucasian

100 (84%)

23 (72%)

0.08

ā€ƒNulliparity

64 (54%)

20 (63%)

0.5

Co-morbidities

ā€ƒPre-existing chronic renal disease

7 (6%)

3 (9%)

0.69

ā€ƒPre-existing diabetes

4 (3%)

0 (0%)

0.67

ā€ƒPre-existing hypertension

21 (18%)

9 (28%)

0.5

ā€ƒGestational diabetes

28 (24%)

3 (9%)

0.13

ā€ƒGestational hypertension

15 (13%)

6 (19%)

0.03

Delivery Outcomes

ā€ƒGestational age at delivery (wk)

38.71 (2.9)

30.64 (8)

<ā€‰0.001

ā€ƒBirth weight (g)

2980 (12.1)

1270 (1387.5)

<ā€‰0.001

ā€ƒApgar score 5ā€‰min

9 (2)

8 (2)

<ā€‰0.001

ā€ƒMode of delivery: C-section

72 (61%)

26 (81%)

0.14

ā€ƒPreterm <ā€‰34ā€‰weeks

33 (28%)

28 (88%)

<ā€‰0.001

ā€ƒSmall for Gestational Age (SGA)

10 (8%)

1 (3%)

0.31

ā€ƒIntrauterine growth restriction (IUGR)

27 (23%)

15 (47%)

0.01

  1. Data are displayed as median (IQR) or n (%). Continuous variables were compared via Wilcoxon rank sum test, categorical variables were compared using Ļ‡2 test
  2. BMI body mass index, kg kilogram, PE preeclampsia, wk week, yr year